Logo

Cost Effectiveness of Lung Cancer Screening and Future Imaging Biomarker Trials Highlight 2011 ACRIN Annual Meeting

September 21, 2011

Cost Effectiveness of Lung Cancer Screening and Future Imaging Biomarker Trials Highlight 2011 ACRIN Annual Meeting

Newswise

September 21, 2011

The American College of Radiology Imaging Network (ACRIN) Annual Meeting —September 21–23, 2011 — offers imaging investigators a science-packed three days of presentations and research planning meetings.

At the plenary session on Thursday morning, September 22:

• ACRIN research results presented include a report by William Black, MD (Dartmouth-Hitchcock Medical Center, Lebanon, NH), on the cost effectiveness of lung cancer screening as carried out in the National Lung Screening Trial.

• ACRIN network chair Mitchell Schnall, MD, PhD, and Robert Comis, MD, Eastern Cooperative Oncology Group (ECOG), will provide information about the organizations’ pending merger and the exciting science expected to emerge as a result of this collaboration.

At the plenary session on Friday morning, September 23:

• A presentation by Keith T. Flaherty, MD (Massachusetts General Hospital Cancer), chair of ECOG’s Developmental Therapeutics Committee, about signaling pathways of cancer cells that offer clues for the development of more effective cancer therapies.

• David Mankoff, MD, PhD (University of Washington, Seattle, WA), chair of ACRIN’s Experimental Imaging Sciences Committee, will provide meeting attendees with an overview on imaging as a cancer biomarker including the goals for such trials and considerations for the development of the ECOG-ACRIN Biomarker Imaging Group that will be the cornerstone of the ECOG-ACRIN merged research agenda.

• Additionally, Reginald Munden, MD, DMD, MBA (MD Anderson Cancer Center, Houston, Texas), chair of the ACRIN Accrual Working Group, will report on the group’s recommendations for improving enrollment of study participants into ACRIN clinical trials.

For a full meeting agenda, visit www.ACRIN.org.

To schedule an interview with an ACRIN representative, please contact Heather Curry at 703-390-9822 or PR@acr.org.

ACRIN is an NCI-sponsored clinical trials cooperative group made up of investigators from over 100 academic and community-based facilities in the United States and abroad. ACRIN’s oncology mission is to develop information through clinical trials of medical imaging that increase the length and quality of life of cancer patients. ACRIN is administered by the American College of Radiology and is headquartered at the ACR Clinical Research Center in Philadelphia, PA. The ACRIN Biostatistics Center is located at Brown University in Providence, RI.

http://www.newswise.com/articles/cost-effectiveness-of-lung-cancer-screening-and-future-imaging-biomarker-trials-highlight-2011-acrin-annual-meeting